According to Renub Research’s latest report, “Israel Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis” the Israel Diabetes Market is estimated to reach US$ 3.22 Billion by 2028. In Israel, Diabetes is a leading cause of death. Diabetes is a long-term disease that rises when blood sugar is too high. The rising population, lack of physical activities, family background, increased awareness among people regarding medical treatment options, and unhealthy meals drive the market. However, the high costs of medicine and lack of reimbursement hinder the market. According to WHO data published in 2020, Diabetes Mellitus Deaths in Israel reached 1,913 total deaths.
The increasing population in Israel creates a primary Type-2 Diabetes disease. Israel Type 2 diabetes is considered an epidemic and continues rising. In Israel, the percentage of diabetes in the Arab population is twice that in the Jewish people. Also, Insulin dependent
